Literature DB >> 20335563

Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients.

Jeffrey L Saver, William G Barsan.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20335563     DOI： 10.1212/WNL.0b013e3181dbe0ad

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


× No keyword cloud information.
  11 in total

1.  Focal CT hypoperfusion in HaNDL.

Authors:  Nuria García Barragán; Marta Guillán; Beatriz Zarza; Cristina González-Gordaliza; Alicia de Felipe Mimbrera; María Alonso de Leciñana; Jaime Masjuan
Journal:  J Neurol       Date:  2012-02-09       Impact factor: 4.849

2.  Usefulness of multimodal MR imaging in the differential diagnosis of HaNDL and acute ischemic stroke.

Authors:  Tomas Segura; Francisco Hernandez-Fernandez; Pedro Sanchez-Ayaso; Elena Lozano; Lorenzo Abad
Journal:  BMC Neurol       Date:  2010-12-02       Impact factor: 2.474

3.  Do efforts to decrease door-to-needle time risk increasing stroke mimic treatment rates?

Authors:  Ava L Liberman; Eric M Liotta; Fan Z Caprio; Ilana Ruff; Matthew B Maas; Richard A Bernstein; Rahul Khare; Deborah Bergman; Shyam Prabhakaran
Journal:  Neurol Clin Pract       Date:  2015-06

4.  Stroke Thrombolysis.

Authors:  William J Meurer; Lesli Skolarus
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-08-15

5.  Multiple Administrations of Intravenous Thrombolytic Therapy to a Stroke Mimic.

Authors:  Ava L Liberman; Daniel Antoniello; Steven Tversky; Michael G Fara; Cen Zhang; Lindsey Gurin; Sara K Rostanski
Journal:  J Emerg Med       Date:  2019-12-03       Impact factor: 1.484

6.  Effects of increasing IV tPA-treated stroke mimic rates at CT-based centers on clinical outcomes.

Authors:  Tina M Burton; Marie Luby; Zurab Nadareishvili; Richard T Benson; John K Lynch; Lawrence L Latour; Amie W Hsia
Journal:  Neurology       Date:  2017-06-28       Impact factor: 9.910

7.  Imaging negative stroke: diagnoses and outcomes in intravenous tissue plasminogen activator-treated patients.

Authors:  Ilana Spokoyny; Rema Raman; Karin Ernstrom; Brett C Meyer; Thomas M Hemmen
Journal:  J Stroke Cerebrovasc Dis       Date:  2013-10-06       Impact factor: 2.136

8.  Tissue-type plasminogen activator for stroke mimics: continuing to be swift rather than delaying treatment to be sure.

Authors:  Waldo R Guerrero; Sean I Savitz
Journal:  Stroke       Date:  2013-04-11       Impact factor: 7.914

9.  Intravenous Tissue Plasminogen Activator in Stroke Mimics.

Authors:  Fatima Ali-Ahmed; Jerome J Federspiel; Li Liang; Haolin Xu; Theresa Sevilis; Adrian F Hernandez; Andrzej S Kosinski; Janet Prvu Bettger; Eric E Smith; Deepak L Bhatt; Lee H Schwamm; Gregg C Fonarow; Eric D Peterson; Ying Xian
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2019-08-15

10.  Thrombolysis of stroke mimics via telestroke.

Authors:  Vivien H Lee; Ravyn Howell; Randheer Yadav; Sharon Heaton; Karen L Wiles; Sushil Lakhani
Journal:  Stroke Vasc Neurol       Date:  2022-02-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.